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Summary Sexual dysfunction in women with epilepsy (WWE) is an important
comorbidity. A significant minority of WWE have markedly decreased sexual
interest and it appears that orgasmic dysfunction occurs more frequently in
WWE than in control women. Enzyme-inducing antiepileptic drugs can adversely
affect sexual functioning by decreasing bioactive testosterone levels. Temporal
lobe epilepsy of right-sided versus left-sided origin may also be a risk factor for
sexual dysfunction. In addition to these factors, emerging evidence suggests that
the serotonin transporter protein is related to temporal lobe epilepsy and it is
postulated that this transporter may play a role in altered sexual functioning in
epilepsy, perhaps through the serotonergic effects of antiepileptic drugs (AEDs).
Strategies for modifying the contributors to sexual dysfunction in WWE will be
discussed as well as the role of the neurologist in initiating management of this
challenging comorbidity.
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Sexual dysfunction in persons with epilepsy is a
comorbidity that has been incompletely explored.
However, there are several reasons to consider its
importance. The high rates of sexual dysfunction in
persons with epilepsy likely are, in some cases, a
manifestation of hypothalamic dysfunction related
to seizures and interictal discharges. This associa-
tion between neurophysiologic brain dysfunction
and reproductive abnormalities is clearly relevant
for neurologists. Further, as difficult as it may be to
explore with patients in the office, sexual well-
being is a high priority for almost everyone. There-
fore, an understanding of the spectrum of sexual
dysfunction in women with epilepsy (WWE) and
approaches to management are worthy of discus-
sion.
In this brief review, evidence for the spectrum of
sexual difficulties in WWE will be presented, as well
as risk factors for such. Potentially modifiable con-
tributors to sexual dysfunction in WWE will be dis-
cussed as well as initial approaches to management.The scope of sexual dysfunction in
women: prevalence and type
The International Consensus Development Confer-
ence on Female Sexual Dysfunction has divided
sexual dysfunction in women into four major cate-
gories: sexual desire disorders, sexual arousal dis-
orders, orgasmic disorders (either primary or
secondary), and sexual pain disorders.1 These are
further subtyped according to duration, timing of
occurrence (situational or generalized), and etiol-
ogy. In the psychological realm, the Diagnostic and
Statistical manual of mental disorders, fourth edi-
tion (DSM-IV-TR; Am. Psychol. Assoc. 2000) defines
two main categories of female sexual disorders,
hypoactive sexual desire disorder, and female sex-
ual arousal disorder. These desire and arousal dis-
orders as defined by the DSM-IV-TR often occur
together.2 The sexual dysfunction described in the
reports discussed herein for WWE will be described
generally within these accepted categories.Type of sexual dysfunction in WWE
One of the first and most insightful reports on
sexuality in WWE was published by Bergen et al.3
The investigators evaluated 50 WWE in a tertiary
epilepsy care center; 32 of 50 women had partial
epilepsy, and 28 of 50 were taking only one AED.
WWE and a comparison group of women of similarage were asked how often they had the desire for
sex, and how often they actually had intercourse.
Equal proportions of women in both groups had a
frequent desire for sex, but several more controls
had very frequent desire compared with none in the
epilepsy group. Further, a much greater proportion
of WWE than comparators had very infrequent sex-
ual desire, with about 20% reporting that they
almost ‘‘never’’ had sexual desire; very few women
in the comparison group reported this low level of
sexual desire. The bimodal distribution persisted for
the actual rate of sexual intercourse and for married
WWE who had a current sexual partner. Therefore,
this difference was not accounted for by access to a
sexual partner. Some WWE had sexual desire more
frequently than they had intercourse, however the
reverse was true in the comparison group. The
investigators found no correlation to age, antiepi-
leptic drugs (AEDs) used, duration of epilepsy, or
seizure type. This report is revealing regarding the
overall picture of sexual dysfunction in WWE: many
WWE have normal sexuality, but there is a significant
fraction who have markedly decreased sexual desire
and this fraction is not present in the general popu-
lation.
Several reports suggest that orgasmic dysfunction
is over-represented among WWE. Jensen et al.4
studied sexuality in 48 WWE and compared their
findings to their own previously reported data on
sexuality in persons with diabetes mellitus and
healthy controls. Although the authors found no
difference in sexual desire between the three
groups, 19% of the WWE had orgasmic dysfunction
compared with 11% of the diabetes mellitus group
and 8% of the controls (P = 0.081). They found no
correlation between sexual dysfunction and type
and duration of epilepsy, or AED use. None of the
WWE had out-of-range testosterone levels, either
free or total, or testosterone-binding globulin
levels.
Inadequate orgasmic satisfaction in WWE, signif-
icant compared with controls, was also reported by
Duncan et al. in their study of 195 WWE from a
hospital-based clinic.5 They also found that sexual
experience scale scores indicated that WWE are
more ‘‘moral’’ and less open to sexual experiences,
but, in general, WWE in relationships seemed to
desire intercourse as much as controls.
In an investigation of self-reported sexual func-
tioning and sexual arousability in 116 WWE, anor-
gasmia was also reported by one third of 17 women
with primary generalized epilepsy and 18 of 99
women with localization-related epilepsy. Com-
pared with historical controls, this group of women
did not have less sexual experience, and reported
less sexual arousability and more sexual anxiety.6
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logic impairment of sexual functioning, that is,
inadequate orgasms or anorgasmia, psychosocial
factors are likely to contribute to self-reported
sexual dysfunction in WWE. For example, living with
the stigma of epilepsy may be an impediment to
social activities. According to a survey of quality of
life in persons with epilepsy across Europe, many
subjects reported low satisfaction with sexual rela-
tionships in the context of feeling stigmatized by
having epilepsy.7
Therefore, many studies support the idea that
although most WWE have normal sexual lives, a
significant minority, about 20—30%, may have some
degree of sexual dysfunction. Orgasmic dysfunction
appears to be specifically over-represented in WWE.Seizures related to orgasm: a rare form
of reflex epilepsy
An obvious reason for anxiety related to sexual
activity is if intercourse seems to precipitate sei-
zures. In a recent report of the rare form of reflex
epilepsy in which orgasm-induced seizures, six sub-
jects, all women, were described as having seizures
within minutes to hours of orgasm during inter-
course.8 The seizures were of varying types, includ-
ing primary generalized convulsions and complex
partial seizures. Interestingly, four of the six sub-
jects had seizures of right temporal origin.Decreased genital blood flow in WWE
Morrell et al.9 reported on genital blood flow (GBF)
measured by vaginal plethysmography in women
with temporal lobe epilepsy as they watched either
erotic or sexually neutral videos. GBF was signifi-
cantly decreased in WWE compared with controls
during erotic visual stimulation. There was no dif-
ference in mood scales between the two patient
and control groups, however, epilepsy subjects were
less sexually experienced than the controls, and
reported more anxiety upon imagining sexual situa-
tions than did controls. Due to small numbers of
subjects, the effect of AEDs on plethysmography
results was not assessed in this study.
The authors proposed a central mechanism for
this effect, that disruption of relevant regions of
cortex by epileptic activity, specifically limbic, and
frontal areas, could be the cause of sexual dysfunc-
tion. The occurrence of decreased GBF in WWE
could, at least in part, contribute to inadequate
orgasm. There is laboratory evidence however, that
testosterone increases vaginal blood flow.10 There-fore, decreased free testosterone levels associated
with hepatic cytochrome P-450 enzyme induction in
women taking enzyme-inducing AEDs may account
for this altered GBF.AEDs and sexual dysfunction
It is well-established that hepatic cytochrome P-450
3A4 isoenzyme-inducing AEDs can lower free testos-
terone levels. This was most recently shown in an
elegant study by Lossius et al.11 in which seizure-free
epilepsy patients appropriate for AED withdrawal
were evaluated for changes in reproductive hormone
levels 4 months after discontinuing the AED. Their
main findings were that total testosterone and free
androgen index (FAI) (100  testosterone/sex hor-
mone binding globulin) significantly increased after
withdrawal from the most frequently used AED, car-
bamazepine, for both genders. In contrast, with-
drawing valproate resulted in nonsignificant
decreases in these parameters. These results indi-
cate that the choice of AED can effect hormones
important for sexual functioning, and that such
alterations are reversible.
All enzyme-inducing AEDs are not the same. In a
report of alterations in reproductive hormone levels
in WWE taking carbamazepine or oxcarbazepine,
both AEDs were associated with relatively total
testosterone level and FAI.12 However, oxcarbaze-
pine-treated subjects had higher dihydroepiandros-
terone (DHEA) and androstendione than controls,
which may be related to the mild inhibitory effect of
oxcarbazepine on the isoenzyme 2C19 metabolic
pathway.
Alternatively, there is evidence that AEDs which
do not induce cytochrome P-450 enzymes have little
effect on these important reproductive hormones.
In a recent study of persons with epilepsy aged
13—80 years randomized to either valproate or
lamotrigine monotherapy, no changes in total tes-
tosterone of FAI were found after 6 or 12 months of
treatment either within each treatment group or by
comparing treatment groups.13
Lamotrigine has specifically been associated with
improvement in sexual functioning, as reported
recently by Gil-Nagel et al.14 In an open study of
141 epilepsy patients changed to lamotrigine mono-
therapy, an overall improvement in self-reported
sexual functioning was found, measured 4 and 8
months after changing AEDs. Women in the study
reported a significant overall improvement in five
dimensions of sexuality including desire/frequency,
desire/interest, pleasure, arousal/excitement, and
orgasm. Men reported an improvement only in the
pleasure dimension. The reason for this improve-
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seizure reduction, changes in overall side effects
or perhaps elevated mood could be contributing
factors.Right-sided epilepsy has more impact
on sexuality than left-sided epilepsy
Reports from different aspects of the epilepsy lit-
erature suggest that seizures of right temporal ori-
gin are particularly associated with reproductive
dysfunction and possibly even sexual ictal phenom-
enon. From the epilepsy surgery literature, Baird
et al. reported that one third of their 58 temporal
lobectomy patients had an increase in sexual activ-
ity after surgery, compared with one quarter of
patients having decreased postsurgical sexual activ-
ity.15 Change in sexuality was more likely to occur in
women and in patients with right-sided resections.
This lateralization of change in sexuality after sur-
gery is consistent with a report by Herzog et al.16
that right temporal epileptic discharges in WWE
were associated with hypogonadotropic hypogonad-
ism that included, for many subjects, decreased
sexual interest. These findings would suggest,
therefore, that right temporal resection could
improve sexual functioning.
In a carefully performed questionnaire study of
sexual functioning in men and women with either
right or left temporal lobe epilepsy, Daniele et al.17
found that sexual interest specifically was
decreased in patients with right temporal lobe epi-
lepsy compared to left for both genders, although
most aspects of sexual performance were not dif-
ferent. Ictal sexual behaviors and ictal orgasm have
been specifically associated with right temporal
epilepsy as well.8
There is also lateralization in the central regula-
tion of gonadotropin secretion: experimental evi-
dence indicates that the right hypothalamus is
predominant in the control of reproductive func-
tioning.18 Therefore, a body of evidence from diver-
gent sources, both clinical- and laboratory-based,
suggest that right-sided epilepsy and right temporal
lobe epilepsy specifically, may be associated with a
risk of sexual and reproductive dysfunction.Is serotonin a factor in epilepsy-
related sexual dysfunction?
Serotonin (5-hydroxytryptamine or 5-HT) is a neuro-
transmitter for which decreased serotonergic activ-
ity, can facilitate seizure activity and exacerbate
seizure severity in animal models.19 The serotonintransporter (5-HTT) is important for 5-HT inactiva-
tion since it is the reuptake site, and is a target for
selective serotonin reuptake inhibitors (SSRIs). SSRI
are known to have anticonvulsant activity in the
laboratory, and further, have as a major side effect,
sexual dysfunction, indicating that serotonin activ-
ity plays an role in sexual functioning. A recent
report has associated a specific 5-HTT genetic poly-
morphism with temporal lobe epilepsy, suggesting
that the serotonin transporter gene may be etiolo-
gically important for the development of temporal
lobe epilepsy.20 This emerging information, com-
bined with evidence that several AEDs affect brain
serotonin concentration, including valproate,21
oxcarbazepine,22 carbamazepine,23 and lamotri-
gine,24 indicate that sexuality in persons with epi-
lepsy may be affected through mechanisms that do
not involve alterations in reproductive hormone
levels or psychosocial influences on behavior. Per-
haps some persons with epilepsy are genetically
susceptible to sexual dysfunction via the serotonin
transport mechanism, or may be vulnerable to the
serotonergic effects of AEDs.Conclusion
How the sexual difficulties of WWE differ
from controls?
WWE have a higher rate of profound lack of sexual
interest and have high rates of orgasmic dysfunc-
tion, including anorgasmia.
What epilepsy-related factors contribute
to sexual dysfunction in WWE?
AEDs that induce cytochrome P-450 isoenzyme 3A4
and therefore decrease free testosterone are asso-
ciated with sexual dysfunction. Right temporal lobe
epilepsy also appears to be associated with sexual
dysfunction compared to left temporal lobe epi-
lepsy. Lack of seizure freedom could adversely
impact psychosocial aspects of living with epilepsy,
including sexuality.
Which contributors to sexual dysfunction
in WWE are modifiable?
Consideration of changing from a highly enzyme-
inducing AED such as carbamazepine, phenytoin, or
phenobarbital when clinically appropriate may be
helpful for persons with epilepsy complaining of
sexual dysfunction. AEDs that are not enzyme indu-
cers could be considered, such as lamotrigine, for
which there is some evidence for improved sexual
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Valproate and levetiracetam are also not enzyme
inducers, and may be reasonable alternatives,
depending on the clinical situation. Clearly, seizure
control is of utmost importance in maximizing qual-
ity of life, including the sexual life, of persons with
epilepsy.
What should the neurologist do?
One of themost refreshing things a neurologist could
do would be to simply ask patients about their
sexual functioning. Although this seems awkward,
it may be an easy segue from the discussion about
bowel or bladder functioning, or from inquiries
about social relationships. Since decreased sexual
interest can be due to depression, the presence of
mood disorders should be screened for when sexual
dysfunction arises as a complaint. Maximizing sei-
zure control and the possibility of adverse sexual
effects due to AEDs should be considered. It is
inherently difficult for a physician to actively
inquire about a medical condition far outside their
comfort zone for initiating treatment. For most
neurologists, it would be most appropriate to refer
such patients to a gynecologist for further evalua-
tion and treatment; an initially laboratory evalua-
tion for women would include total and free
testosterone, sex hormone binding globulin, estro-
gen follicle-stimulating hormone, and luteinizing
hormone levels.References
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